Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

BioParacetamol A Sustainable Biocatalytic Alternative for Paracetamol Production

Coordinator
Technische Universiteit Delft, Netherlands
Runs
1 October 2025 to 31 March 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101248607

What the project is doing

In the project's own words, from its summary on CORDIS.

Current paracetamol production relies on century-old chemical methods that have significant environmental drawbacks, including high energy consumption, low process efficiency, and substantial waste generation. The BioParacetamol solution offers a more sustainable alternative by using enzymes to catalyse reactions at lower temperatures, producing fewer toxic by-products. This innovative process utilises a simplified one-pot, two-step synthesis, reducing energy demands, increasing efficiency, and minimising waste, particularly harmful by-products.

Designed to be both scalable and commercially viable, BioParacetamol presents a major opportunity for the pharmaceutical industry to adopt greener chemistry practices. The BioParacetamol innovation is still in the early stages of development, with a technology readiness level (TRL) of 2, but aims to reach higher TRLs through rigorous testing and optimisation. The project’s primary goal is to demonstrate the feasibility of this process at an industrial scale, alongside a comprehensive business feasibility study to evaluate its commercial potential.

BioParacetamol represents a high-risk, high-gain opportunity with the potential to not only improve the environmental footprint of paracetamol production but also position Europe as a leader in sustainable pharmaceutical manufacturing.

Topics

Who is involved

OrganisationCityCountryRole
Technische Universiteit DelftDelftNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI